SLEEP, STRESS & CALM RESEARCH

DSIP

Delta Sleep-Inducing Peptide, a naturally occurring neuropeptide studied for sleep architecture and stress regulation.

DSIP (Delta Sleep-Inducing Peptide) is a naturally occurring neuropeptide first isolated in 1977, studied for its effects on sleep architecture and stress regulation. Human research exists but remains limited, with a described role in slow-wave sleep and HPA-axis balance.

Sleep NeuropeptideSlow-Wave SleepCortisol BalanceStress Regulation

Why BLP features DSIP

Included because it has early human research and a described role in sleep and stress regulation, with a growing but still developing use history. It represents an emerging sleep-research compound rather than an established one.

Mechanism

Crosses the blood-brain barrier and modulates GABA, glutamate, and stress pathways.

Described as normalizing sleep spindles and slow-wave (delta) sleep.

Lowers cortisol and balances the HPA axis; described as a physiological reset for the sleep-wake cycle.

WHAT THE RESEARCH MEASURED

Research findings

Findings describe study outcomes, not expected personal results.

Human research findings

  • Early human research reports faster sleep onset and longer sleep duration.
  • Reported waking refreshed without grogginess, and lower daily stress and anxiety.
  • Reported improved mood and faster recovery from sleep debt.
  • Considered one of the gentlest peptides; side effects extremely rare.

Preclinical findings

  • Sleep-architecture and HPA-axis effects documented in early research.
  • Mechanism partially characterized; further human data limited.

Regulatory status

DSIP is investigational with limited human clinical data. Sold and offered strictly for laboratory and research use.